Open Access

[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

  • Authors:
    • Yi Zhou
    • Zhigang Ji
    • Weigang Yan
    • Zhien Zhou
    • Hanzhong Li
    • Yu Xiao
  • View Affiliations

  • Published online on: September 16, 2024     https://doi.org/10.3892/or.2024.8811
  • Article Number: 152
  • Copyright : © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

November-2024
Volume 52 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou Y, Ji Z, Yan W, Zhou Z, Li H and Xiao Y: [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1. Oncol Rep 52: 152, 2024.
APA
Zhou, Y., Ji, Z., Yan, W., Zhou, Z., Li, H., & Xiao, Y. (2024). [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1. Oncology Reports, 52, 152. https://doi.org/10.3892/or.2024.8811
MLA
Zhou, Y., Ji, Z., Yan, W., Zhou, Z., Li, H., Xiao, Y."[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1". Oncology Reports 52.5 (2024): 152.
Chicago
Zhou, Y., Ji, Z., Yan, W., Zhou, Z., Li, H., Xiao, Y."[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1". Oncology Reports 52, no. 5 (2024): 152. https://doi.org/10.3892/or.2024.8811